International Journal of Cardiology
Volume 135, Issue 3 , Pages 302-307 , 10 July 2009

Increased muscle sympathetic nerve activity predicts mortality in heart failure patients

  • Antonio C.P. Barretto

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Amilton C. Santos

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Robinson Munhoz

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Maria U.P.B. Rondon

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Fábio G. Franco

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Ivani C. Trombetta

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Fabiana Roveda

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Luciana N.J. de Matos

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Ana M.W. Braga

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • ,
  • Holly R. Middlekauff

      Affiliations

    • Department of Cardiology, University of California Los Angeles, USA
    • ,
  • Carlos E. Negrão

      Affiliations

    • Heart Institute (InCor), University of São Paulo, Medical School, Brazil
    • School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Instituto do Coração (InCor) — Unidade de Reabilitação Cardiovascular e Fisiologia do Exercício, Av. Dr. Enéas de Carvalho Aguiar, 44 – Bloco II – 1°, Subsolo, Cerqueira César – São Paulo – SP, CEP 05403–000 — Brazil. Tel.: +55 11 3069 5699; fax: +55 11 3069 5043.

Received 11 December 2007 ,Accepted 6 March 2008.

References 

  1. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650–654
  2. Francis GS, Golsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med. 1984;101:370–377
  3. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation. 1990;82:1724–1729
  4. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin–angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659–1666
  5. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233–243
  6. Negrao CE, Rondon MU, Tinucci T, et al. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol. 2001;280:H1286–H1292
  7. Esler M, Kaye D. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev. 2000;5:17–25
  8. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823
  9. Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol. 1996;28:1183–1189
  10. Kinugawa T, Ogino K, Osaki S, et al. Prognostic significance of exercise plasma noradrenaline levels for cardiac death in patients with mild heart failure. Circ J. 2002;66:261–266
  11. Davis D, Baily R, Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol. 1988;254:E760–E766
  12. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615–621
  13. Wallin BG, Delius W, Sundlof G. Human muscle nerve sympathetic activity in cardiac arrhythmias. Scand J Clin Lab Invest. 1974;34:293–300
  14. Vanhoutte PM. Adjustments in the peripheral circulation in chronic heart failure. Eur Heart J. 1983;4:67–83
  15. Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968;47:960–970
  16. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovascular Dis. 1982;24:437–459
  17. Middlekauff HR, Nitzsche EU, Nguyen AH, Hoh CK, Gibbs GG. Modulation of renal cortical blood flow during static exercise in humans. Circ Res. 1997;80:62–68
  18. Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V, Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol. 2005;25:1174–1179
  19. Fischer D, Rossa S, Landmesser U, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J. 2005;26:65–69
  20. Delius W, Hagbarth KE, Hongell A, Wallin BG. Maneuvers affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand. 1972;84:82–94
  21. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919–957
  22. Santos AC, Alves MJ, Rondon MU, Barretto AC, Middlekauff HR, Negrao CE. Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol. 2005;289:H593–H599
  23. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310–314
  24. Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–193
  25. Krizanac-Bengez L, Mayberg MR, Cunningham E, et al. Loss of shear stress induces leukocyte-mediated cytokine release and blood–brain barrier failure in dynamic in vitro blood–brain barrier model. J Cell Physiol. 2006;206:68–77
  26. von Haehling S, Genth-Zotz S, Anker SD, Volk HD. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol. 2002;85:173–183
  27. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 1997;18:259–269
  28. Piepoli MF, Kaczmarek A, Francis DP, et al. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation. 2006;114:126–134
  29. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol. 2002;39:653–663
  30. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005;25:332–336
  31. Gielen S, Adams V, Mobius-Winkler S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;42:869–872
  32. Hambrecht R, Schulze PC, Gielen S, et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005;12:401–406

☆ Grants: This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo – SP (# 2005/59740-7), and in part by Fundação Zerbini, São Paulo – SP, Brazil. Carlos E Negrão (CNPq # 304304/2004-2), Maria Urbana P. B. Rondon (CNPq # 305159/2005-4), and Ivani C. Trombetta (CNPq # 306931/2006-0) were supported by Conselho Nacional de Pesquisa (CNPq).

PII: S0167-5273(08)00527-5

doi: 10.1016/j.ijcard.2008.03.056

International Journal of Cardiology
Volume 135, Issue 3 , Pages 302-307 , 10 July 2009

Article Tools

* Image Usage & Resolution